Ontogen Medtech
Private Company
Funding information not available
Overview
Ontogen Medtech is a private, US-based service provider in the medical device and drug delivery sectors, founded in 2019. The company operates as a contract development and manufacturing organization (CDMO), offering comprehensive services from initial concept and prototyping through regulatory clearance (e.g., 510(k), IDE) and commercial-scale manufacturing. Its business model targets entrepreneurs, startups, and established companies, providing strategic, engineering, regulatory, and quality management support to accelerate time-to-market for a wide range of medical devices. Ontogen is revenue-generating, deriving income from client service contracts and project-based work.
Technology Platform
Integrated service platform for medical device development, including regulatory strategy, design/engineering, quality management, and ISO 13485 contract manufacturing.
Opportunities
Risk Factors
Competitive Landscape
Ontogen competes with a fragmented array of players, including boutique design firms, specialized regulatory consultancies, and large-scale contract manufacturers. Its key differentiator is the integration of strategy, development, regulatory, and manufacturing under one roof, targeting clients who prefer a single, accountable partner over managing multiple vendors.